Telemedicine rules for controlled drugs will stay loose until 2027

The US Drug Enforcement Administration will continue to allow doctors to prescribe controlled medications via telemedicine without an in-person visit. This extension lasts until the end of 2026, giving patients continued access to remote care for conditions like ADHD or opioid use disorder.

During the pandemic, the government temporarily relaxed rules that required an in-person visit before prescribing controlled substances. This allowed millions of people to get care remotely. This fourth extension means that patients who rely on telemedicine for these medications will not suddenly lose access, and providers can continue to offer remote services without interruption. The long-term question of whether these flexibilities become permanent is still being debated.